Skip to main content
Walter Stadler, MD, Oncology, Chicago, IL, University of Chicago Medical Center

WalterMStadlerMD

Oncology Chicago, IL

Genitourinary Oncology, Hematologic Oncology

Fred C. Buffett Professor of Medicine & Surgery, Associate Dean for Clinical Science Research, Clinical Trials Senior Advisor to the Director, UCCCC

Overview of Dr. Stadler

Dr. Walter Stadler is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Yale School of Medicine and has been in practice 29 years. Dr. Stadler accepts several types of health insurance, listed below. He is one of 123 doctors at University of Chicago Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1991 - 1994
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1988 - 1991
  • Yale School of Medicine
    Yale School of MedicineClass of 1988

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1988 - 2026
  • IN State Medical License
    IN State Medical License 2023 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly
  • Chicago Magazine: Top Doctors Castle Connolly
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Ca...  
    Michael B Atkins, Mario Sznol, Robert J Motzer, Richard W Joseph, Thomas Hutson, John Hainsworth, W Kimryn Rathmell, Brian I Rini, David F McDermott, Toni K Choueiri, ..., Nature
  • Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Carcinoma  
    Michael B Atkins, Thomas Hutson, Mario Sznol, Toni K Choueiri, Sumanta K Pal, Richard W Joseph, John Hainsworth, W Kimryn Rathmell, David F McDermott, Robert J Motzer,..., Nature

Authored Content

  • Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic CancersJanuary 2018

Press Mentions

  • The Caris Precision Oncology Alliance Welcomes University of Chicago Medicine Comprehensive Cancer Center
    The Caris Precision Oncology Alliance Welcomes University of Chicago Medicine Comprehensive Cancer CenterMarch 8th, 2023
  • Stand up to Cancer Announces Four Teams Focused on Diversity in Early Phase Cancer Clinical Trials
    Stand up to Cancer Announces Four Teams Focused on Diversity in Early Phase Cancer Clinical TrialsFebruary 8th, 2023
  • Myovant’s Phase III Relugolix Trial’s Cardiovascular Event Reduction Trend Inconclusive
    Myovant’s Phase III Relugolix Trial’s Cardiovascular Event Reduction Trend InconclusiveJune 18th, 2020
  • Join now to see all

Grant Support

  • Protocol Review And Monitoring SystemNational Cancer Institute2008–2012
  • Dynamic-Contrast Enhanced MRI As A BAY 43-9006 MarkerNational Cancer Institute2005–2006
  • Biomarkers For Bladder Cancer Chemoprevention TrialsNational Cancer Institute1998–1999

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois BlueChoice Select
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    First Health PPO
    Great West PPO
    HealthLink PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Sagamore Health Plus
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment